AA
Aarey Drugs & Pharmaceuticals
AAREYDRUGS.BO · BSE
₹95.76 +0.97% (+₹0.92)
1M +11.80%
Market Cap ₹2.69B
P/E Ratio 54.93x
Div. Yield -
ROE 3.53%
Piotroski F-Score Moderate
4/9Valuation
33 /100
Expensive P/E 54.93x
EV/EBITDA 25.25x
P/S 0.57x
Growth
31 /100
Declining EPS growth 12.96%
Rev. growth 4.38%
Book val. growth 10.33%
Profitability
8 /100
Weak Gross margin 5.04%
Net margin 1.03%
Op. margin 3.12%
Quality
34 /100
Average ROIC 5.78%
ROE 3.53%
ROA 1.65%
Debt
57 /100
Moderate Debt/Equity 0.33x
Current ratio 1.81x
Int. coverage 1.72x
Stability
53 /100
Moderate Beta 1.25x
Rev. volatility 30.13%
EPS volatility 34.69%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre AAREYDRUGS.BO
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mihir Rajesh Ghatalia
Employees
132
Headquarters
Mumbai